Skip to content
ThermaSolutions – Hyperthermic Intraperitoneal ChemotherapyThermaSolutions – Hyperthermic Intraperitoneal Chemotherapy
  • Request Info
  • Contact
  • Our Story
  • Products
    • HT-2000
    • HT-2500 (CE)
    • HurriChem Device Kit (FDA)
    • HurriChem Nebulizer (CE)
    • Whole Body Hyperthermia: HEATT
    • Disposable HIPEC Procedure Kits
    • Chemo Waste Products (US)
    • Isolated Limb Products
    • SurgiChem Dual Injector Pump
    • Thermal Insulators (US)
    • Lasso Tubing Drains
    • ThermoChem Accessories
  • Distributors
    • Find Us
    • Distributors Only
    • Product Inquiry Form
    • PSO Form
  • Training & Support
    • IPH Kit: Training Videos
    • TSP Kits: Training Videos
    • HIPEC Program Support
    • HIPEC Resources
    • Support for HT-1000
    • Product Manuals & IFU
    • Customer Feedback
  • Job Openings
  • News
News

Great article on CRS-HIPEC Outcomes from a ThermaSolutions partner in cancer care site

Posted on February 26, 2024February 26, 2024 by Dean Wennerberg

 

https://www.sciencedirect.com/science/article/abs/pii/S0002961024000333

This entry was posted in News. Bookmark the permalink.
SSO ACT Conference 2024 – San Juan, Puerto Rico March 16-19
Singhealth Peritoneal Surface Oncology Conference (SPSOC) is 25-26 April 2024
Categories
  • HIPEC Resources
  • News
Recent Posts
  • 4th Congreso Latinoamericano de Neoplasias Peritoneales
  • European Surgical Oncology events in France and Belgium
  • ThermaSolutions Sponsors Events – Fall 2024 – We hope to see you at one of these events……
  • ISSPP-PSOGI Event in Lyon, France – 26-28 September 2024
  • PIPAC Training at Stony Brook University August 1-2, 2024
Past Events

Our Certifications

21 CFR Quality Systems Regulation Part 820 of the Federal Food and Drug Administration (FDA).
EN/ISO 13485:2016 • MDD 93/42/EEC

Follow Us

U.S. Headquarters

1889 Buerkle Road
White Bear Lake, MN 55110
Tel. +1 651 209 3900
Fax +1 651 209 3903

Toll Free: +1 877 952 6100

General Questions:

International Office

Takkebijsters 41
4817 BL Breda
The Netherlands
Tel. +31 76 579 1144

Direct:

Products

  • ThermoChemTM HT-2000
  • ThermoChemTM HT-2500
  • Disposable HIPEC Procedure Kits
  • Find Us
  • Distributors Only

Training & Support 

  • IPH Kit: Training Videos
  • TSP Kit: Training Videos
  • HIPEC Program Support
  • HIPEC Resources
  • Support for HT-1000

*FDA Disclaimer: ThermoChem™ HT-2000 (or HT-1000) has not been cleared for use to treat any specific disease state or condition. Chemotherapy drugs used during the Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedure are currently approved for the treatment of certain cancers. A number of clinical studies and literature exist regarding the use of HIPEC in the peritoneum using intraperitoneal heating devices, such as the ThermoChem™ HT-2000 (or HT-1000). Physicians should decide which drugs to use with ThermoChem™ HT-2000 (or HT-1000) based upon their good judgment and understanding of the strengths and limitations of the data, and should consider the literature to guide their use of HIPEC with ThermoChem™ HT-2000 (or HT-1000).

  • Home
  • Request Info
  • News
  • Privacy statement
  • Disclaimer
2024 © ThermaSolutions
Site by Gasman Design
  • Home
  • Our Story
  • Products
    • HT-2000
    • HT-2500 (CE)
    • HurriChem Device Kit (FDA)
    • HurriChem Nebulizer (CE)
    • Whole Body Hyperthermia: HEATT
    • Disposable HIPEC Procedure Kits
    • Chemo Waste Products (US)
    • Isolated Limb Products
    • SurgiChem Dual Injector Pump
    • Thermal Insulators (US)
    • Lasso Tubing Drains
    • ThermoChem Accessories
  • Distributors
    • Find Us
    • Distributors Only
    • Product Inquiry Form
    • PSO form
  • Training & Support
    • IPH Procedure Kit: Training Videos
    • TSP Kits: Training Videos
    • HIPEC Program Support
    • HIPEC Resources
    • Support for HT-1000
    • Product Manuals & IFU
    • Customer Feedback
  • Request Info
  • Job Openings
  • News
  • Contact Us